Clinical Trials Logo

Personality Disorders clinical trials

View clinical trials related to Personality Disorders.

Filter by:

NCT ID: NCT05428462 Completed - Clinical trials for Borderline Personality Disorder

Effectiveness of a One-day Psychoeducation Program on Internalized Stigmatization for BPD Patients

EDUC-BPD
Start date: January 1, 2021
Phase:
Study type: Observational

Education day on borderline personality disorder (BPD), including a transmission of current scientific knowledge on the disease. A dimensional understanding of BPD is delivered as well as disidentification of oneself to the symptoms of borderline personality disorder (Ducasse 2020 Eur Arch Psychiatry Clin Neurosci). The main objective is to evaluate the impact of borderline education day on self-stigma.

NCT ID: NCT05418270 Completed - Aging Clinical Trials

Anorexia and Personality Traits in Elderly Individuals

APETI
Start date: June 2, 2022
Phase:
Study type: Observational

The aim of this study is to evaluate the relationship between age-related anorexia and personality traits in elderly individuals with comorbidities.

NCT ID: NCT05383300 Completed - Clinical trials for Antisocial Personality Disorder

Intranasal Oxytocin in Antiosocial Personality Disorder and Psychopathy

OXYASP
Start date: May 1, 2017
Phase: N/A
Study type: Interventional

A pharmacoimaging study of oxytcoin in antisocial personality disorder and psychopathy

NCT ID: NCT05357521 Completed - Clinical trials for Borderline Personality Disorder

Interplay Between Oxytocin and Cortisol During Stress in Borderline Personality Disorder

OXT-CORT-BPD
Start date: March 1, 2022
Phase:
Study type: Observational

This study aims to determine the feasibility and preliminary data on the interaction between oxytocin and cortisol during stress in borderline personnality disorder.

NCT ID: NCT05289583 Completed - Clinical trials for Borderline Personality Disorder

Impact of Therapeutic Alliance on Dropout in a Naturalistic Sample of Patients With Borderline Pathology Receiving Residential DBT

DBT_dropout2
Start date: January 1, 2019
Phase:
Study type: Observational

Participants with Borderline pathology (≥ 3 DSM-IV-criteria) receiving an inpatient Dialectical Behavior Therapy (DBT) program completed a quality assurance questionnaire set assessing demographic information and pretreatment psychopathology during the days of their inpatient stay. Beyond that, changes of therapists were documented.

NCT ID: NCT05191329 Completed - Clinical trials for Patient Satisfaction

Impact of Personality on Satisfaction Following Presbyopic Correction

Start date: August 28, 2021
Phase:
Study type: Observational [Patient Registry]

Primary objective of this study is the exploration of the impact of personality type, social roles and working mandates οn the visual capacity and satisfaction of patients that underwent pseudophakic presbyopic correction.

NCT ID: NCT05162287 Completed - Clinical trials for Personality Disorders

Child and Adolescent Psychiatric Personality Structure

CAPPS
Start date: December 1, 2021
Phase:
Study type: Observational

The study plan outlined here represents an investigation of instruments on the patients treated in the acute ward of child and adolescent psychiatry at the University Medical Center Hamburg Eppendorf (UKE). The psychosocial burden of the affected children and adolescents is evident due to the severity of the disorders leading to specific admission. The psychosocial burden can be defined as "psychological, social, or school-occupational functional impairment [...] that has arisen as a consequence of a mental disorder, a specific developmental disorder, or an intellectual impairment". The current research project aims to survey the severity of psychosocial distress, personality functioning impairment, and social withdrawal. A better knowledge of these factors may contribute to a more suitable, specialized treatment offer on the acute ward in the medium term.

NCT ID: NCT05025670 Completed - Clinical trials for Borderline Personality Disorder

Tracking Response in Advance of Investigational Trials, Borderline Study

TRAIT-BOR
Start date: August 5, 2021
Phase:
Study type: Observational

TRAIT-BOR is an open-label psychotherapy treatment study for adults who meet the diagnostic criteria for Borderline Personality Disorder (BPD) and are seeking enrollment in a clinical trial of a novel compound to treat BPD. The current study seeks to determine if there are therapeutic benefits to more infrequent, short term, or longer term supportive psychotherapy.

NCT ID: NCT05014217 Completed - Clinical trials for Borderline Personality Disorder

Comparing Mentalization-based Treatment And A Dialectical Behavior Therapy-inspired Treatment On The Utilization Of Services And The Dropout Rate In A Clinical Adult Population With A Cluster B Personality Disorder

Start date: January 1, 2015
Phase:
Study type: Observational

Cluster B personality disorders (borderline, narcissistic, antisocial and/or histrionic) are an important clinical consideration because of their high prevalence and associated morbidity. Although many studies examine borderline personality disorder, few of them explore cluster B personality disorders as a whole. In clinical practice, personality disorders are frequently comorbid. Patients who receive services in specialized clinics for these disorders often have a complex diagnosis that include many cluster B personality disorders. Therefore, our study globally examines patients with cluster B personality disorders even though borderline personality disorder is empirically the most studied psychopathology. Previous data suggests that borderline personality disorder has a prevalence of 2% in the general population, of 25% in the clinical psychiatric population and of 15% in all visits to the emergency room. Furthermore, it is associated with social costs estimated from 15,000$ to 50,000$ USD per patient per year. In Quebec, this psychopathology is associated with an increased mortality rate compared to the general population, totaling a loss of nine years for women and 13 years for men of life expectancy. Other studies suggest that borderline personality disorder is often comorbid with other personality disorders, including those in cluster B. The population with comorbid personality disorders have a worse prognosis and a lower chance of reaching symptomatic remission, which is the reason why it is crucial to better understand and study patients with cluster B personality disorders. The study compares the effectiveness of two psychotherapies for borderline personality disorder, mentalization-based therapy and a modified version of Linehan's dialectical behavior therapy, in a retrospective naturalistic study of patients with at least one cluster B personality disorder who have undergone either treatment. The scarcity of data on cluster B personality disorders and on the comparison between MBT and DBT further highlights the necessity of a naturalistic study like ours to examine both aspects and bring research closer to the clinical setting. Based on clinical observations, the investigators believe that there will be no statistically significant difference between either treatment.

NCT ID: NCT04978441 Completed - Clinical trials for Diabetes Mellitus, Type 1

The Influence of Personality Characteristics and Emotions on Blood Glucose Levels Among Type 1 Diabetes Mellitus Patients

Start date: February 17, 2020
Phase:
Study type: Observational

The research goal is to find a correlation between patient personality characteristics, patients' mood and glycemic control. Eventually, using this information may allow treating physicians the ability to better balance glucose blood levels in patients with T1DM, by recognizing influencing psychological parameters. The conclusion from this research will add to other physiological parameters that are being studied today, and in the future will be integrated into an artificial pancreas. The investigators believe that there is a correlation that hasn't been studied in the past between personality characteristics, daily emotions and the ability to balance glucose blood levels in patients with T1DM.